Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy w...
Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
SelectMDx is a urinary biomarker test for determining prostate cancer risk.
Aim
In a group of patients with a biopsy proven prostate cancer (PCa) who had undergone a multi parametric Magnetic Resonance Imaging (mpMRI) and urinary biomarker test with SelectMDx, we studied the additive value of SelectMDx to mpMRI and correlated th...
Alternative Titles
Full title
Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_12e9a9d66ccd4c4b9555047405b8e2a1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_12e9a9d66ccd4c4b9555047405b8e2a1
Other Identifiers
ISSN
2573-8348
E-ISSN
2573-8348
DOI
10.1002/cnr2.1396
